scholarly journals Clinical Management of a Peri-Implant Giant Cell Granuloma

2015 ◽  
Vol 2015 ◽  
pp. 1-7
Author(s):  
A. Pacifici ◽  
D. Carbone ◽  
R. Marini ◽  
G. L. Sfasciotti ◽  
L. Pacifici
Keyword(s):  
Giant Cell ◽  
Dental Implant ◽  
Correct Diagnosis ◽  
Excisional Biopsy ◽  
Giant Cell Granuloma ◽  
Peripheral Giant Cell Granuloma ◽  
Natural Teeth ◽  
Implant Therapy

Purpose. Implant therapy plays an important role in contemporary dentistry with high rates of long-term success. However, in recent years, the incidence of peri-implantitis and implant failures has significantly increased. The peripheral giant cell granuloma (PGCG) rarely occurs in peri-implant tissues and it is clinically comparable to the lesions associated with natural teeth. Therefore, the study of possible diseases associated with dental implants plays an important role in order to be able to diagnose and treat these conditions.Materials and Methods. This report described a 60-year-old Caucasian male who presented a reddish-purple pedunculated mass, of about 2 cm in diameter, associated with a dental implant and the adjacent natural tooth.Results. An excisional biopsy was performed and the dental implant was not removed. Histological examination provided the diagnosis of PGCG. After 19-month follow-up, there were no signs of recurrence of peri-implantitis around the implant.Conclusion. The correct diagnosis and appropriate surgical treatment of peri-implant giant cell granuloma are very important for a proper management of the lesion in order to preserve the implant prosthetic rehabilitation and prevent recurrences.

scholarly journals Peripheral giant cell granuloma associated with a dental implant

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Rafaela Carriço Porto Baesso ◽  
Maria Carolina de Lima Jacy Monteiro Barki ◽  
Rebeca de Souza Azevedo ◽  
Karla Bianca Fernandes da Costa Fontes ◽  
Débora Lima Pereira ◽  
...  
Keyword(s):  
Giant Cell ◽  
Histological Examination ◽  
Dental Implant ◽  
Excisional Biopsy ◽  
Giant Cells ◽  
Giant Cell Granuloma ◽  
Case Presentation ◽  
Peripheral Giant Cell Granuloma ◽  
Left Mandible

Abstract Background Peripheral giant cell granuloma (PGCG) is an uncommon pathology that affects gingival or alveolar mucosa. Although PGCG can be associated with dental implants, little is known about this lesion and implant osseointegration as well as its etiopathogenesis and the treatments available. This study sought to report a rare case of PGCG associated with dental implant, emphasizing its clinical and histopathological aspects. Case presentation A 53-year-old man had an exophytic, reddish lesion, around a crown attached to a dental implant located in the left mandible. Radiographically, there was bone loss around the implant. After excisional biopsy, histological examination revealed a submucosal proliferation of multinucleated giant cells rendering the diagnosis of peripheral giant cell granuloma. Patient has been under follow-up for 6 months with no recurrence. Conclusions Peri-implant lesions must be completely removed to prevent recurrence of PGCG and implant failure, even in cases suspected to be reactive. Besides, histological examination must be performed on all peri-implant reactions to achieve the appropriate diagnosis and, consequently, the best treatment and follow up.

scholarly journals Peripheral Giant Cell Granuloma Associated with a Dental Implant: A Case Report and Review of the Literature

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Amy Louise Brown ◽  
Paulo Camargo de Moraes ◽  
Marcelo Sperandio ◽  
Andresa Borges Soares ◽  
Vera Cavalcanti Araújo ◽  
...  
Keyword(s):  
Giant Cell ◽  
Dental Implant ◽  
Excisional Biopsy ◽  
Giant Cells ◽  
Infectious Agents ◽  
Giant Cell Granuloma ◽  
Review Of The Literature ◽  
Peripheral Giant Cell Granuloma ◽  
Foreign Body Reactions

The peripheral giant cell granuloma (PGCG) is a nonneoplastic lesion commonly caused by local irritation. This report describes a 46-year-old Caucasian male who presented with a PGCG associated with a dental implant. The dental implant was originally placed in August 2012. Ten months later, the patient presented with a well-circumscribed lesion associated with and covering the implant, at which time the lesion was excised. Four months later, due to recurrence of the lesion, a deeper and wider excisional biopsy with curettage of the adjacent bone was performed. No evidence of recurrence has been reported after 12 months of follow-up. Immunohistochemistry, using the antibody CD68, was performed to investigate the origin of the multinucleated giant cells, with their immunophenotype being similar to those of other giant cell lesions, including central giant cell granuloma, foreign-body reactions, and granulomatous reactions to infectious agents.

A Case of Giant Cell Granuloma of Maxillary Sinus: Long-Term Follow-Up

2009 ◽  
Vol 52 (3) ◽  
pp. 284 ◽  
Author(s):  
Hyeong-Jun Jang ◽  
Se-Joon Oh ◽  
Kyu-Sup Cho ◽  
Hwan-Jung Roh
Keyword(s):  
Maxillary Sinus ◽  
Giant Cell ◽  
Giant Cell Granuloma ◽  
Long Term Follow Up

Peripheral Giant Cell Granuloma Associated With Dental Implants: Clinical Case and Literature Review

2012 ◽  
Vol 38 (S1) ◽  
pp. 527-532 ◽  
Author(s):  
Maria A. Peñarrocha-Diago ◽  
Juan Cervera-Ballester ◽  
Laura Maestre-Ferrín ◽  
David Peñarrocha-Oltra
Keyword(s):  
Giant Cell ◽  
Dental Implants ◽  
Histological Study ◽  
Complete Resection ◽  
Fourth Quadrant ◽  
Giant Cell Granuloma ◽  
Peripheral Giant Cell Granuloma ◽  
Soft Tissue Complication ◽  
Fixed Prosthesis

Peripheral giant cell granuloma (PGCG) associated to dental implants is a very infrequent peri-implant soft-tissue complication, with only 11 cases recorded in the literature to date. The present study describes a 54-year-old woman presenting a swelling of the alveolar margin in the fourth quadrant in relation to a fixed prosthesis cemented over implants. Treatment consisted of complete resection of the lesion with implantoplasty of the exposed implant threads. The diagnosis of PGCG was confirmed by histological study, and no relapse has been recorded after 12 months of follow-up.

scholarly journals Peripheral giant cell granuloma associated with a dental implant: A case report

2021 ◽  
pp. e1049-e1052
Author(s):  
A. Sánchez-Torres ◽  
B. Pérez-Amate ◽  
A. Javier ◽  
I. Cercadillo-Ibarguren ◽  
R. Figueiredo ◽  
...  
Keyword(s):  
Case Report ◽  
Giant Cell ◽  
Dental Implant ◽  
Giant Cell Granuloma ◽  
Peripheral Giant Cell Granuloma

scholarly journals Central Giant Cell Granuloma Treated with Intralesional Corticosteroid Injections and Bisphosphonates: A Long-Term Follow-Up Case Study

2019 ◽  
Vol 14 (2) ◽  
pp. 497-502 ◽  
Author(s):  
Raíssa Pinheiro de Mendonça ◽  
Geovanni Pereira Mitre ◽  
Flavio Henrique Real ◽  
Maria Sueli da Silva Kataoka ◽  
Sérgio de Melo Alves Júnior ◽  
...  
Keyword(s):  
Giant Cell ◽  
Giant Cell Granuloma ◽  
Central Giant Cell Granuloma ◽  
Intralesional Corticosteroid ◽  
Long Term Follow Up ◽  
Corticosteroid Injections

Management of recurrent central giant cell granuloma of mandible using intralesional corticosteroid with long-term follow-up

2020 ◽  
Vol 13 (9) ◽  
pp. e237200
Author(s):  
Kumar Nilesh ◽  
Anuj Dadhich ◽  
Rahul Patil
Keyword(s):  
Giant Cell ◽  
Osteolytic Lesion ◽  
Giant Cell Granuloma ◽  
Central Giant Cell Granuloma ◽  
Intralesional Corticosteroid ◽  
Ablative Surgery ◽  
Long Term Follow Up ◽  
Intralesional Injections

Central giant cell granuloma (CGCG) is an expansile osteolytic lesion of the jawbone. Conventional treatment of CGCG is surgical and vary from simple curettage to more aggressive resection of the jaw. However, surgical management is associated with drawbacks including requirement of hospitalisation and general anaesthesia, damage to vital anatomic structures and continuity defect of the mandible requiring reconstruction surgery. Use of intralesional injections of corticosteroid for the management of CGCG have been inconsistently used as an alternative non-surgical method of management of CGCG with varying success. While the use of such conservative modality over ablative surgery can significantly reduce postoperative morbidity, follow-up of such cases for a long period is important to study the possible recurrence. This paper reports successful treatment of a recurrent CGCG of posterior mandible by intralesional administration of triamcinolone acetonide in a 27-year old female patient, with long-term follow-up of 10 years.

Sign in / Sign up

Export Citation Format

Share Document